Current Options
Current treatments are intended to improve symptoms and slow disease progression. As yet, there is no cure for IPF. A
panel of experts sponsored by the American Thoracic Society and the European Respiratory Society has developed guidelines
for the treatment of IPF. This panel concluded that no effective therapy for IPF has been identified. However, given the
poor long-term outcome of the disease and the apparent partial response to available therapy, they recommended the
following approach to treatment:
- A corticosteroid (such as prednisone) to reduce inflammation
used in combination with
- A drug to suppress the body's immune response (azathioprine or cyclophosphamide)
Unfortunately, this treatment approach makes people feel better and/or improves their lifespan only some of the time.
These drugs can also cause side effects—some minor and some more serious. Be sure to contact your doctor or nurse if
you have any negative reactions to your medications.
For more information on these medications, click here.
Lung Transplantation
Oxygen Management and Pulmonary Rehabilitation
Prescription Reimbursement Information
Click here for reimbursement information for expenses and drug costs related to the treatment of IPF.
|
